Bill

Bill > S1197


MA S1197

MA S1197
Relating to LSDs (Lysosomal Storage Disorders) in infants


summary

Introduced
01/23/2017
In Committee
01/23/2017
Crossed Over
Passed
Dead
12/31/2018

Introduced Session

190th General Court

Bill Summary

For legislation relative to LSDs (Lysosomal Storage Disorders) in infants. Public Health.

AI Summary

This bill amends Section 110A of Chapter 111 of the General Laws in Massachusetts to add several Lysosomal Storage Disorders (LSDs) - Krabbe, Fabry, Gaucher, Pompe, MPS I, and Niemann Pick A/B disease - to the list of conditions that must be included in the newborn screening program. LSDs are a group of rare genetic disorders that affect the body's ability to break down and recycle specific substances, leading to a buildup that can cause severe health problems. The addition of these LSD conditions to the mandatory newborn screening will help ensure early detection and prompt treatment to improve health outcomes for affected infants.

Committee Categories

Health and Social Services

Sponsors (7)

Last Action

Accompanied a study order, see S2422 (on 04/12/2018)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...